ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer

September 30, 2005

ACCC T Discuss Personnel, Fund Sources, Clinical Research At Annual Meeting

January 9, 1976

Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan

August 30, 2013

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage

July 18, 2014